Shivakumar Sonnaila
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Instructor
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shivakumar Sonnaila's research focuses on fibroblast growth factors (FGFs) and their roles in biological processes, including homeostasis and signaling pathways. His work has investigated the structural and functional properties of FGF1, exploring how modifications, such as charge reversal in its heparin-binding pocket, can enhance stability and activity. Sonnaila has also examined the overexpression and purification of mitogenic and metabolic FGFs. His recent publications also extend into the application of CRISPR-Cas systems for diagnosing and potentially treating COVID-19, as well as gene-slicing in cancer research. Additionally, his work touches upon the etiology and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Sonnaila collaborates with researchers at the University of Arkansas at Fayetteville, including Shilpi Agrawal, Phuc Phan, Thallapuranam Krishnaswamy Suresh Kumar, and Zeina Alraawi.
Metrics
- h-index: 4
- Publications: 10
- Citations: 100
Positions
-
Instructor publications 2021–2026University of Arkansas at Fayetteville Institution web page
Selected Publications
-
Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1 (2026)
-
Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment (2025)
-
Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications (2025)
-
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics (2024)
-
Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors (2024)
-
CRISPR-Cas9 Unleashed: Gene-Slicing Adventures in the Cancer Battlefield (2024)
-
Design and characterization of hyper stable variant of human fibroblast growth factor1 (hFGF1) (2023)
-
Design of variants of human fibroblast growth factor 1 with enhanced stability and cell proliferation activity (2022)
-
The Saga of Endocrine FGFs (2021)
Collaboration Network
Top Collaborators
- The Saga of Endocrine FGFs
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
- CRISPR-Cas9 Unleashed: Gene-Slicing Adventures in the Cancer Battlefield
- Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1
- The Saga of Endocrine FGFs
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors
- The Saga of Endocrine FGFs
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- The Saga of Endocrine FGFs
- Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment
- The Saga of Endocrine FGFs
- The Saga of Endocrine FGFs
- Overexpression and Purification of Mitogenic and Metabolic Fibroblast Growth Factors
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
- Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications
Similar Researchers
Based on overlapping research topics